Application of the International Classification of Functioning, Disability and Health system to symptoms of the Duchenne and Becker muscular dystrophies.
Kristin M Conway, Emma Ciafaloni, Dennis Matthews and 4 others
PMID 28395534WHAT IT FOUND
Clinician reviewers selected 24 of 78 ICF body-function categories for childhood-onset Duchenne and Becker muscular dystrophies, but only 15 could be linked to medical-record data.
It is a documentation framework, not evidence of treatment benefit.
Key findings
01Clinician reviewers selected 24 of 78 possible second-level ICF body-function categories for childhood-onset dystrophinopathies.
02Fifteen of the 24 retained second-level categories could be linked to MD STAR net surveillance data.
03Language and swallowing categories were retained, but speech function categories were not.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The categories were chosen by two clinicians, and agreement was calculated only for second-level categories. The linkage used retrospectively collected medical-record data, not tests ordered for a specific purpose, and 9 of the 24 retained second-level categories could not be linked. Activity and participation information was not collected in the surveillance database, so the paper cannot describe how dystrophinopathy affects daily life or social roles. Hawaii was excluded from the record analysis because follow-up was limited. The study did not test any therapy or compare groups, so it cannot show that a rehabilitation plan based on these categories improves outcomes.
Declared interests
Data collection and writing were supported by Centers for Disease Control and Prevention cooperative agreements; the authors report no conflicts of interest.
The easy way to misread this
Do not read the selected ICF categories as a validated dystrophinopathy core set or as proof that therapy works. They were chosen by two clinicians and only 15 of the 24 retained second-level categories could be linked to medical-record data; no therapy was tested.